Protara Therapeutics(TARA)
NEW YORK, NYBiotechnology
Focus: Protara Therapeutics is a publicly traded biotech company focused on cell therapy and gene therapy for rare and specialized indications. The company operates with a lean footprint as a clinical-stage developer with no marketed products.
Profile data last refreshed 21h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About Protara Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Protara Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
6 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Prevalence of Liver Disease in Patients Dependent on Parenteral Nutrition
Intestinal Failure-associated Liver DiseaseClinical Trials (1)
NCT05011370Prevalence of Liver Disease in Patients Dependent on Parenteral Nutrition
N/AHelp build intelligence for Protara Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.